Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: Amersham Pharmacia Biotech Lands Two Texas Universities for Proteomics Platform

This story has been updated from a previous version.

NEW YORK, June 6 – Amersham Pharmacia Biotech announced Tuesday an agreement to supply their Ettan proteomics system to Dallas' Center for Biotechnology and Bioinformatics at the University of Texas and the Alliance for Cellular Signaling at the University of Texas Southwestern Medical Center. 

Under the terms of the agreement, both research centers will have early access to AP Biotech’s systems for protein separation, isolation, and analysis. 

“The technology is ready to use, it just may not have the bells and whistles yet,” Andy Bertera, AP Biotech director of drug discovery marketing for North America, told GenomeWeb.

Bertera explained that under the early access agreement, the research organizations pay a fee to get pre-marketing access to hardware, software, reagents, training, and support. The arrangement allows the organizations to forward their research while providing AP Biotech with early placement of the technology and user feedback, said Bertera.

Financial terms of the agreement were not disclosed.

“We need to understand the relationship between proteins in a given biochemical pathway,” Alfred Gilman, chairman of pharmacology at UT Southwestern, said in statement. “With the knowledge of how proteins interact within a cell and between cells, we can approach disease states and drug discovery from a more informed vantage point.”

The Alliance for Cellular Signaling, a collection of 52 investigators at 21 different institutions, plans to use the Ettan system to identify proteins making up cellular signaling systems in order to explore how different compartments within a cell communicate with each other and with neighboring cells. The AFCS has stated that it will “establish a large, public database of virtually all useful information about these molecules, including links to evolving maps of signaling pathways.” 

AFCS labs are located at UT Southwestern, the San Francisco Veteran's Administration Medical Center, Stanford University, the California Institute of Technology, and the University of California, San Diego. 

The Center for Biotechnology and Bioinformatics was established in 1999 to provide the University of Texas at Dallas with the resources to research genomics and proteomics for biomedical and agricultural applications. 

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.